Kimberly McAlarney

Kimberly McAlarney is a seasoned professional in the pharmaceutical and medical sales industry with extensive experience in various roles. Currently serving as a Business Account Executive at Alnylam Pharmaceuticals since September 2024, Kimberly focuses on rare disease and polyneuropathy manifestations of hATTR amyloidosis. Previously, Kimberly worked as a Cardiology Account Specialist at scPharmaceuticals, where responsibilities included launching Furoscix for heart failure patients. Earlier roles include Account Executive at Myriad Genetics, where Kimberly achieved notable success in quota attainment and product incorporation, as well as Senior Territory Executive Manager at ZOLL Medical Corporation, managing partnerships with various cardiology specialists. Additional experience includes sales roles at Warner Chilcott and Forest Pharmaceuticals, alongside an initial position as an Event Coordinator at the El Paso Convention Center. Kimberly holds a Master's degree in Business/Corporate Communications from UTEP and a Bachelor of Arts in Communications from the University of the Incarnate Word.